Journal of Biological Chemistry · 2000 · 166 citations · 29 references
Life SciencesCell BiologyMolecular BiologyCell SignalingProtein-protein InteractionsSignal TransductionCytokine Receptor SignalingOncogenic Signaling PathwaysProtein DegradationTumor Suppressor GenesSh2 DomainsSrc Homology 2 DomainsSuppressor Of Cytokine Signaling RegulationTumor Suppressor PathwaysUbiquitin-mediated DegradationUbiquitin-mediated ProteolysisVon Hippel-lindau DiseaseVon Hippel-lindau Syndrome
Suppressor of cytokine signaling-1 (SOCS1) is an inducible Src homology 2 (SH2)-containing protein that negatively regulates cytokine and growth factor signaling required during thymic development. Recent evidence indicates that SOCS1 interacts with elongins B and C, which are components of a ubiquitin ligase complex, VCB (VHL/elonginC/B), based on the VHL (von Hippel Lindau) tumor suppressor protein. SOCS1 has previously been shown to operate as an inhibitor of Janus kinases. Here we show that SOCS1 has the distinct function of targeting the hematopoietic specific guanine nucleotide exchange factor, VAV, for ubiquitin-mediated protein degradation. VAV and SOCS1 form a protein complex through interactions between the VAV NH(2)-terminal regulatory region and the SH2 domain of SOCS1 in a phosphotyrosine-independent manner. SOCS1 decreases the steady state levels of cotransfected VAV and onco-VAV and reduces the focus forming activity of onco-VAV. SOCS1 stimulates the polyubiquitination of VAV proteins in vivo, which was stabilized by proteasomal inhibitors. These results suggest that SOCS1 programs VAV degradation by acting as a substrate-specific recognition component of a VCB-like ubiquitin ligase complex.
29
A family of cytokine-inducible inhibitors of signalling
Robyn Starr, Tracy A. Willson, Elizabeth M. Viney et al. · Nature · 1997 · 2.1K citations
A new protein containing an SH2 domain that inhibits JAK kinases
Takaho A. Endo, Masaaki Masuhara, Masahiro Yokouchi et al. · Nature · 1997 · 1.4K citations
Structure and function of a new STAT-induced STAT inhibitor
Tetsuji Naka, Masashi Narazaki, Moritoshi Hirata et al. · Nature · 1997 · 1.3K citations · Full text